Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Menorrhagia: later-stage trial registry

1 of 11 indexed Menorrhagia trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #1,577 of 28,707 conditions by registered trial count.

11 US clinical trials · 1 currently recruiting · #1,577 of 28,707 conditions by registered trial count

Menorrhagia: 11 US clinical trials tracked, 1 recruiting.

Menorrhagia is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Ferring Pharmaceuticals, running 2 of these trials.

Enrollment posture brief

Registry condition menorrhagia

OPEN 1 | RECR 9% | LATE 3 | EARLY 0 | RANK #1577 | SPON 2

Nearest open-share peer: Advanced Cancers (9% recruiting · 11 trials)

Acute Pancreatitis81.8%Acute Stroke45.5%Acquired Brain Injury36.4%Acute Lung Injury9.1%Menorrhagia (this)9%
Open-enrollment share among volume-matched conditions near Menorrhagia

Menorrhagia lists 1 open slots (9% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Menorrhagia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Menorrhagia is recruiting below its size-band peers.

    1 of 11 indexed trials (9.1%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Menorrhagia research.

    Ferring Pharmaceuticals accounts for 2 of 11 trials (18.2%). 10 distinct sponsors appear on at least one study for this condition label.

  3. Typical Menorrhagia enrolment sits around 165 participants.

    Median target enrolment is 165 among the 11 trials that report a genuine target (sentinel values excluded). 2 of those (18.2%) plan for fewer than 100 participants.

  4. Menorrhagia research is mostly interventional.

    9 interventional and 2 observational studies make up this index (81.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 33

Open and recent trials

11 total, page 1 of 1

RECRUITING 300 participants

A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device

Channel Medsystems

NCT05922657

COMPLETED NA 621 participants

Hysteroscopic Assessment of Fallopian Tubal Patency

University of Mississippi Medical Center

NCT02005263

COMPLETED Phase 3 288 participants

A Study of Tranexamic Acid (XP12B) in Women With Heavy Menstrual Bleeding

Ferring Pharmaceuticals

NCT01280981

COMPLETED NA 219 participants

Minitouch Endometrial Ablation System Treatment for Menorrhagia: An Evaluation of Safety & Effectiveness

MicroCube

NCT04267562

COMPLETED Phase 3 196 participants

Efficacy and Safety Study of XP12B in Women With Menorrhagia

Ferring Pharmaceuticals

NCT00386308

COMPLETED Phase 3 165 participants

Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)

Bayer

NCT00360490

COMPLETED NA 153 participants

Minerva Pivotal Study to Evaluate Safety and Efficacy of the Aurora Endometrial Ablation System Compared to Hysteroscopic Rollerball Ablation

Minerva Surgical

NCT01569763

COMPLETED NA 147 participants

Sonography Guided Transcervical Ablation of Uterine Fibroids

Gynesonics

NCT02228174

COMPLETED NA 100 participants

Surgical Success After Laparoscopic vs Abdominal Hysterectomy

University of Texas Southwestern Medical Center

NCT01793584

COMPLETED 80 participants

Ultrasound Appearance of the Endometrium Post Radio-Frequency Ablation

TriHealth

NCT02584088

COMPLETED NA 17 participants

Tranexamic Acid (TA) vs Combined Oral Contraceptive (COCP) Pilot Study

Baylor College of Medicine

NCT01428713

Phase Distribution

PhaseTrial count
Phase 3 3

Named interventions

Most-linked intervention names on Menorrhagia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Intrauterine Ultrasound-Guided Radiofreq. Ablation System Device
1 trials
Oral Contraceptive Pills Drug
1 trials
Oral tranexamic acid Drug
1 trials
Levonorgestrel IUS (Mirena, BAY86-5028) Drug
1 trials
Minitouch System Device
1 trials
Salpingography Procedure
1 trials
Placebo tablets Drug
1 trials
Rollerball Ablation/Resection Device
1 trials

US sites by state

Facility locations filed on Menorrhagia trials. A trial with sites in several states counts in each.

Texas 5 trials
Arizona 5 trials
Florida 4 trials
Colorado 4 trials
Ohio 3 trials
Missouri 3 trials
Indiana 3 trials
California 3 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Menorrhagia page

11 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Menorrhagia condition card totals 11 registered trials; most-linked intervention Intrauterine Ultrasound-Guided Radiofreq. Ablation System; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.